Asabys Partners
Investor profile
Venture capital
Deals
16
distinct rounds
Companies
13
backed
Active span
2019–2026
8 yrs
Total round €
€660M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Ysios Capital3
- Aliath Bioventures2
- Columbus Venture Partners2
- Gilde Healthcare2
- Mérieux Equity Partners2
- New Enterprise Associates2
- Novartis Venture Fund2
- Sanofi Ventures2
- Sofinnova Partners2
- UCB Ventures2
- Wellington Partners2
- Adara Ventures1
- Alta Life Sciences1
- Amadeus Capital Partners1
- APEX Ventures1
- Avançsa1
- Axis-Ico1
- Bpifrance1
- Buenavista Equity Partners1
- Build Collective1
- CDTI1
- CDTI Innvierte1
- CGHealth Ventures1
- COFIDES1
- Creas1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| SpliceBio | Spain | 2 | €168M |
| Agomab Therapeutics | Belgium | 1 | €83M |
| Ona Therapeutics | Spain | 1 | €74M |
| Sidekick Health | Iceland | 2 | €69M |
| Inbrain Neuroelectronics | Spain | 2 | €61M |
| Quibim | Spain | 1 | €50M |
| Deepull | Spain | 1 | €50M |
| Qida | Spain | 1 | €37M |
| Anaconda Biomed | Spain | 1 | €20M |
| Medlumics | Spain | 1 | €18M |
| Gradient Denervation Technologies | France | 1 | €14M |
| SafeHeal | France | 1 | €10M |
| Cara Care | Germany | 1 | €6.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| SpliceBio | Series B | €118M | 2025-06 |
| Agomab Therapeutics | Series D+ | €83M | 2024-10 |
| Ona Therapeutics | Series B | €74M | 2026-06 |
| Sidekick Health | Series B | €52M | 2022-05 |
| SpliceBio | Series A | €50M | 2022-02 |
| Deepull | Series C | €50M | 2025-04 |
| Quibim | Series A | €50M | 2025-01 |
| Inbrain Neuroelectronics | Series B | €46M | 2024-10 |
| Qida | Other | €37M | 2025-11 |
| Anaconda Biomed | Series B | €20M | 2019-09 |